Plasma (Follow It®)
Canexia Health’s Follow It panel detects mutations in plasma. Plasma profiling (a type of liquid biopsy) can be used to help tailor treatment, monitor cancer progression, or detect treatment resistance.
If you are looking to repatriate your precision oncology program to your laboratory, Canexia Health’s proprietary software platform puts the control back in your hands without the need for costly infrastructure overhead.
The Canexia Health Insights Platform seamlessly integrates with your internal systems to provide an accurate and high-throughput suite for molecular and computational genome analysis, quality assurance, interpretation, and report generation from targeted next-generation sequencing (NGS) data at the individual or population level.
The fully automated scalable system provides the security, traceability, data management, and performance required for NGS data in a clinical setting.
Custom sequence pre-processing to variant annotation with built-in, rigorous, proprietary quality control (QUALITY NEXUS™)
Store, manage, and analyze anonymized, aggregate data for assay improvement, ensuring data integrity and scalability
Information from over 30 sources, curated and reviewed by a team of scientists and experts. Includes both single variant and combination variant interpretations
Auto-generated clinical reports are seamlessly integrated into partners' LIMS.
Each report includes carefully vetted recommendations for consideration, provided in the context of a primary cancer type
Canexia's therapeutic recommendations are based on gene mutations and the clinical data provided
Clinical trials included have been reviewed and selected by certified clinical molecular geneticists.
Canexia Health’s Follow It panel detects mutations in plasma. Plasma profiling (a type of liquid biopsy) can be used to help tailor treatment, monitor cancer progression, or detect treatment resistance.
Canexia Health’s Find It & Fusions panels detect mutations and gene fusion events in solid tumor tissue. Tissue profiling can be used to help inform treatment decisions or predict progression of cancer based on somatic mutations found in the tumor.
Contact us to schedule time with one of our PhD-level Customer Success team members.